LEADER 01135nam  2200361Ka 450 
001 9910698581003321
005 20080811154032.0
035   $a(CKB)3360000000454672
035   $a(OCoLC)243474491
035   $a(EXLCZ)993360000000454672
100   $a20080811d2007      ua             0
101 0 $aeng
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 04$aThe prostate-specific antigen (PSA) test$b[electronic resource] $equestions and answers
210  1$a[Bethesda, Md.] :$cNational Cancer Institute,$d[2007]
215   $a6 pages $cdigital, PDF file
225 1 $aFact sheet ;$v5.29
300   $aTitle from title screen (viewed on Aug. 11, 2008).
300   $a"8/21/07."
517   $aProstate-Specific Antigen 
606   $aProstate-specific antigen
606   $aCancer$xTreatment
615  0$aProstate-specific antigen.
615  0$aCancer$xTreatment.
712 02$aNational Cancer Institute (U.S.)
801  0$bGPO
801  1$bGPO
906   $aBOOK
912   $a9910698581003321
996   $aThe prostate-specific antigen (PSA) test$93509317
997   $aUNINA